Lumason Contrast-Enhanced Ultrasound Scan for the Imaging of Kidney Masses in Patients with Suspected Kidney Cancer

This phase IV trial studies how well lumason contrast-enhanced ultrasound scan works in identifying kidney masses in patients with suspected kidney cancer. Lumason is a type of contrast containing tiny bubbles that can be used in imaging procedures, including contrast-enhanced ultrasound. Performing lumason contrast-enhanced ultrasound imaging, may allows doctors to identify features of kidney masses that may help determine how aggressive the masses may act.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03821376.

Trial PhasePhase IV

Trial Typediagnostic

Lead OrganizationIndiana University/Melvin and Bren Simon Cancer Center

Principal InvestigatorJordan Swensson

• Primary IDRADY-IIR-CORRELATION
• Secondary IDsNCI-2019-06046, 1901057253
• ClinicalTrials.gov IDNCT03821376